Huons Meditech recently announced that it has secured European medical device certification (CE-MDR) for its Premium 9-Pin Needle, a specialized injection needle designed for skin booster treatments.
The Premium 9-Pin Needle is engineered to work in conjunction with aesthetic drug delivery systems like the Derma Shine Pro and Derma Shine Balance. It features an innovative laser-marked rotation adjuster, allowing for precise depth control during procedures.
The needle’s optimized bevel angle and length significantly reduce drug leakage and minimize patient discomfort during treatments.
This certification follows the CE-MDR approval of the Derma Shine Pro and Derma Shine Balance devices in August last year. The latest certification further validates the safety and efficacy of the Premium 9-Pin Needle under the recently strengthened CE-MDR regulations.
With this certification in hand, Huons Meditech is poised to make a significant entry into the European market. The company’s strategic plan involves expanding its presence from Europe to Asia and the Americas, with the ultimate goal of establishing itself as a global brand in the medical device industry.
Chang-woo Hu, Chief Executive Officer (CEO) of Huons Meditech, emphasized the importance of this achievement, stating that this CE-MDR certification marks a crucial milestone in the global expansion strategy, particularly in the European market. It remains committed to driving innovation and developing cutting-edge products that showcase the excellence of Korean medical devices on the world stage.
Huons Meditech, a subsidiary of the Huons Group, specializes in the development and manufacture of medical devices for aesthetics, infection control, and extracorporeal shockwave therapy.
